Open Access. Powered by Scholars. Published by Universities.®
Translational Medical Research Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- COVID-19 (22)
- SARS-CoV-2 (14)
- Pneumonia (6)
- HIV (5)
- Cancer (3)
-
- Coronavirus (3)
- Infection (3)
- Inflammation (3)
- Vaccination (3)
- Abstracts (2)
- Cardiology (2)
- Chlamydia (2)
- Community-Acquired Pneumonia (2)
- Cytokine storm (2)
- Graduate medical education (2)
- Health research (2)
- Infection prevention (2)
- Neuroscience (2)
- Oncology (2)
- Pandemic (2)
- Pharmacy (2)
- Primary care (2)
- Public health (2)
- RSV (2)
- Respiratory syncytial virus (2)
- SARS-CoV2 (2)
- Symposium (2)
- Treatment (2)
- Vaccine (2)
- 3D printing (1)
- Publication Year
- Publication
-
- The University of Louisville Journal of Respiratory Infections (36)
- Clinical Research in Practice: The Journal of Team Hippocrates (11)
- Center for Translational Medicine Faculty Papers (3)
- Journal of Patient-Centered Research and Reviews (2)
- Bioengineering Dissertations - Archive (1)
-
- Capstone Experience: Master of Public Health (1)
- Dartmouth College Ph.D Dissertations (1)
- Engagement & Service-Learning Summit (1)
- Journal of Health Disparities Research and Practice (1)
- Natural & Applied Sciences Faculty Publications (1)
- Phase 1 (1)
- School of Veterinary and Biomedical Sciences: Dissertations, Theses, and Student Research (1)
- Theses and Dissertations--Clinical and Translational Science (1)
- Publication Type
Articles 61 - 61 of 61
Full-Text Articles in Translational Medical Research
Primary And Secondary Prevention Of Hepatitis C Virus Among Rural Appalachian People Who Use Drugs, Dustin B. Stephens
Primary And Secondary Prevention Of Hepatitis C Virus Among Rural Appalachian People Who Use Drugs, Dustin B. Stephens
Theses and Dissertations--Clinical and Translational Science
Hepatitis C virus (HCV) remains a major cause of morbidity and mortality worldwide, with 3% of the global population chronically infected. Clinical impacts in the United States are projected to increase for two decades, and mortality attributed to HCV now exceeds HIV. Injection drug use (IDU) is the most common route of transmission in the developed world. Advances in treatment offer hope of mitigating HCV impacts, but substantial barriers obstruct people who inject drugs (PWID) from receiving care, particularly in medically underserved regions including Central Appalachia. This study assessed IDU paraphernalia sharing longitudinally over 24 months in a sample of …